Enova® is Available Now in C Haptic Model

(PresseBox) - VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL. Enova® is the first and only 100% Glistening-Free, Dry-Packed hydrophobic acrylic IOL. Moreover, no warming or special conditioning is required before surgery!

VSY Biotechnology Launches Enova® 100% Glistening-Free Hydrophobic Acrylic IOL in C Haptic Model. The unique composition of Enova® material allows uniform hydration of specific sites to have controlled water uptake and resistance to glistening formation. Glistening study was performed at the Intermountain Ocular Research Center (Mamalis/Werner  Laboratory), John A. Moran Eye  Center, University of Utah and the unique composition of Enova® hydrophobic acrylic  IOL shows Zero Glistening and Zero Haze compared with other IOLs1.

Enova® is packaged dry and has excellent optical and mechanical properties. Having a Tg -2°C, Enova® IOL has gentle and controlled unfolding process below standard operating room temperatures. Thus, no warming or special conditioning is required. Low glass transition temperature (Tg -2°C) combined with its optimized modulus of elasticity, provides a high level of flexibility and controlled unfolding.

For more information, visit https://www.vsybiotechnology.com/enova/

Reference:

1. Glistening Analysis in Enova Hydrophobic Acrylic Intraocular Lenses / In-vitro Study Evaluating the Tendency of Different Intraocular Lenses to Form Intraoptical Glistenings by the University of Utah.

https://www.vsybiotechnology.com/wp-content/uploads/2021/01/White-Paper_Glistening-Analysis-in-Enova.pdf

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: PresseBox
Datum: 04.06.2021 - 14:45 Uhr
Sprache: Deutsch
News-ID 638887
Anzahl Zeichen: 1838

contact information:
Town:

Leinfelden-Ecterdingen

Kategorie:

Diese Pressemitteilung wurde bisher 519 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Enova® is Available Now in C Haptic Model"
steht unter der journalistisch-redaktionellen Verantwortung von

VSY Biotechnology GMBH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

VSY Biotechnology Appoints Can Ongen to Board of Directors ...

VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of seasoned executive leader Can Ongen to the company?s Board of Directors. In this role, Can Ongen will also lead VSY Biotechnol ...

VSY Biotechnology GmbH, Signs Agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. o ...

VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter ...

Thanks to VSY Biotechnology, ophthalmologist will have more comfortable surgery ...

VSY Biotechnology provides the best vision to people worldwide and supplies the best technology to ophthalmologists. The company?s Pre-loaded IOL System Patent has been granted by the Japan Patent Office. VSY Biotechnology?s innovations are indeed fo ...

Alle Meldungen von VSY Biotechnology GMBH